Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Pharm Biomed Anal. 2013 Aug 31;88:10.1016/j.jpba.2013.08.033. doi: 10.1016/j.jpba.2013.08.033

Figure 3.

Figure 3

Figure 3

Intensive pharmacokinetic results evaluating the long term storage stability of clinical samples at room temperature from two different dosing days (first dose, i.e. Day 1 and Day 30). The Y axis represents the mean of measured TFV (3a Day 1;3b Day 30) and FTC (3c Day 1;3d Day 30) of three subjects at the respective time point and dosing days from the initial run (solid line) and re-run (dashed line). The elapsed time between two runs was 404 days.